Literature DB >> 7806598

Opiate antagonists for the treatment of schizophrenia.

E B Welch1, D F Thompson.   

Abstract

Numerous studies suggest that opiate antagonists may have antipsychotic properties. A review of the literature describing the use of naloxone to treat schizophrenic patients has shown mixed results. The three studies on naltrexone have found no benefit in controlling auditory hallucinations. We present a synopsis of these studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806598     DOI: 10.1111/j.1365-2710.1994.tb00814.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study.

Authors:  Elizabeth Scarr; Tammie Terese Money; Geoffrey Pavey; Jaclyn Neo; Brian Dean
Journal:  BMC Psychiatry       Date:  2012-08-28       Impact factor: 3.630

2.  Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Med Sci Monit       Date:  2020-09-06

3.  The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.